Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Project

Accellerating towards clinical validation of Galsome nanovaccines

Information

Project Team

Organisations

Outputs and Outcomes

Publications

Alpha-galactosylceramide improves the potency of mRNA LNP vaccines against cancer and intracellular bacteria

Sofie MeulewaeterIlke AernoutJoke DeprezYanou EngelenMargo De VelderLorenzo FranceschiniKarine BreckpotSerge Van CalenberghCaroline AsselmanKatie BoucherFrancis ImpensStefaan De SmedtRein VerbekeIne Lentacker et al.

A1 Journal Article in JOURNAL OF CONTROLLED RELEASE

2024